Anderson Woodrow D purchased $54K of INDV
Anderson Woodrow D (Chief Accounting Officer) purchased 1,500 shares of Indivior Pharmaceuticals, Inc. (INDV) at $36.28 on 2026-08-05.
How this was made
The 30-second read
Why it matters
Traders may monitor for follow-on insider activity, but the filing alone does not change fundamentals or near-term expectations.
Market read
A routine insider open-market buy was disclosed, offering only a modest sentiment signal.
What to watch
The transaction is small relative to company size and lacks any stated rationale; without follow-on buys or company guidance, signal strength is weak.
Background
The article is a SEC Form 4 insider transaction disclosure for Indivior Pharmaceuticals, Inc.
Ticker impact
Indivior disclosed a Form 4 showing Chief Accounting Officer Anderson Woodrow D bought 1,500 shares at $36.2800 on 2026-08-05.
Likely limited near-term impact; any effect would be sentiment-driven and small.
The filing is a routine insider transaction with no 10b5-1 plan and no accompanying company-specific operational or financial disclosure.
Market effects
No clear sector read-through; this is company-specific insider activity.
None indicated.
None indicated.
Counterpoint
Insider purchases can be discretionary and may reflect diversification or personal liquidity needs rather than a strong earnings outlook.
Key entities
- issuerIndivior Pharmaceuticals, Inc.
Subject of the Form 4 insider transaction disclosure.
- insiderAnderson Woodrow D
Chief Accounting Officer who reported an open-market purchase.
